Prostate Cancer Detection with IsoPSA®

IsoPSA® is covered for men aged 50 and older with a confirmed moderately elevated PSA (>4 to ≤25 ng/mL) who are suitable candidates for prostate biopsy. PSA elevation must be reverified after a few weeks under standardized conditions in a CLIA-approved laboratory, and testing is not indicated for men with less than a 10-year life expectancy or other contraindications to biopsy.

"Men age >=50 with a confirmed moderately elevated PSA (>4 and <=25 ng/mL)."

Sign up to see full coverage criteria, indications, and limitations.